RPS6KA1 and melanoma: This inhibition of RSK1 phosphorylation byS100B, coupled with its inhibition of the RSK1 C-terminal kinase domain,explains how S100B blocks the MAPK signal cascade via RSK1 in malignant melanoma[29].